Lipid Nanoparticle Mediated Inhibition and Detection of Matrix Metalloproteinases
脂质纳米颗粒介导的基质金属蛋白酶的抑制和检测
基本信息
- 批准号:8255348
- 负责人:
- 金额:$ 27.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-16 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Liposomes are one of the best representatives of lipid-based nanoparticles, and they are ideally suited as the drug delivery vehicles due to their ease in formulations as well as biocompatibility. Aside from drug carriers, the liposomal nanoparticles have potentials to form template surfaces against proteins (due to intrinsic mobility of their lipid monomers), and such features can be contrived to develop highly specific diagnostic and desensitization protocols for proteins of biomedical relevance. The proposed research will develop novel liposome-based artificial antibodies , which will find applications in isozyme specific detection and inhibition of four matrix metalloproteinases (viz., MMP-2, MMP-7, MMP-9, and MMP-10), which are known to be involved in the pathogenesis of a variety of human diseases. These fundamental, process developmental , research will be accomplished under the following specific aims: (i) Synthesis of lipid conjugates to serve as the initial anchor sites for MMPs, as well as for interaction at the protein surfaces. (ii) Template polymerization of liposomes in the presence of each of the MMPs (i.e., MMP-2, -7, -9 and -10), and testing the potentials of resultant (polymerized) liposomes in isozyme selective inhibition of their parent MMPs. (iii) Isozyme-selective detection of the MMPs by employing time-resolved luminescence spectroscopy of liposome-incorporated lanthanide ions. (iv) Mechanistic studies on the roles of protein-lipid interactions in isozyme-selective detection and inhibition of MMPs. These research objectives will be accomplished by employing the techniques of synthetic organic chemistry, molecular biology, fluorescence spectroscopy, and kinetic and thermodynamic analyses of enzyme-ligand interactions and enzyme catalyses. The successful completion of this research will provide insights into developing liposomal nanoparticle-based highly specific and facile diagnostic tools for other pathogenic as well as biomarker proteins under diverse pathophysiological conditions. PUBLIC HEALTH RELEVANCE: The outcome of the proposed research will find long term applications in diagnosing and treating various cancers. During this application period, we will focus our attention in designing novel lipid nanoparticles, and in understanding the basic mechanistic principles intrinsic to the detection and inhibition of several enzymes involved in the progression and metastasis of various cancers. The successful completion of this research will establish foundation for developing diagnostic and therapeutic tools for other proteins responsible for causing different human diseases.
描述(由申请人提供):脂质体是基于脂质的纳米颗粒的最佳代表之一,由于它们易于制剂和生物相容性,因此理想地将其作为药物输送车。除药物载体外,脂质体纳米颗粒具有对蛋白质形成模板表面的潜力(由于其脂质单体的固有迁移率),并且可以为生物医学相关性蛋白质提供高度特定的诊断和脱敏方案而产生这种特征。拟议的研究将开发出新型的基于脂质体的人造抗体,该抗体将在同工酶特异性检测和抑制四种基质金属蛋白酶(viz。,MMP-2,MMP-7,MMP-9,MMP-9和MMP-10)中的应用,已知参与各种人类疾病的发病机制。这些基本的过程发展,研究将以以下特定目的完成:(i)脂质共轭物的合成作为MMP的初始锚固位点以及在蛋白质表面上的相互作用。 (ii)在每个MMP(即MMP -2,-7,-9和-10)存在下脂质体的模板聚合,并测试产生(聚合)脂质体在同工酶选择性抑制其母体MMP中的电势。 (iii)通过使用脂质体掺入的灯笼离子的时间分辨发光光谱来对MMP进行同工酶选择性检测。 (iv)关于蛋白脂相互作用在同工酶选择检测和抑制MMP中的作用的机理研究。这些研究目标将通过采用合成有机化学,分子生物学,荧光光谱以及动力学和热力学分析的技术来实现。这项研究的成功完成将为开发基于脂质体纳米颗粒的高度特异性且功能齐全的诊断工具提供见解,以在多样化的病理生理条件下为其他致病性和生物标志物蛋白质以及生物标志物蛋白。公共卫生相关性:拟议研究的结果将在诊断和治疗各种癌症时找到长期应用。在此应用期间,我们将注意力集中在设计新型的脂质纳米颗粒上,并在理解检测和抑制各种癌症进展和转移的几种酶的基本机理原理上。这项研究的成功完成将为开发诊断和治疗工具的基础,以针对负责引起不同人类疾病的其他蛋白质。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential modulation of the active site environment of human carbonic anhydrase XII by cationic quantum dots and polylysine.
- DOI:10.1016/j.bbapap.2010.02.014
- 发表时间:2010-06
- 期刊:
- 影响因子:0
- 作者:Manokaran S;Zhang X;Chen W;Srivastava DK
- 通讯作者:Srivastava DK
Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I.
稳定人碳酸酐酶 I 活性位点的阴离子和中性形式的荧光配体。
- DOI:10.1016/j.bbapap.2010.06.024
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Manokaran,Sumathra;Banerjee,Jayati;Mallik,Sanku;Srivastava,DK
- 通讯作者:Srivastava,DK
Differentiation of prostate cancer cells using flexible fluorescent polymers.
- DOI:10.1021/ac202301k
- 发表时间:2012-01-03
- 期刊:
- 影响因子:7.4
- 作者:Scott, Michael D.;Dutta, Rinku;Haldar, Manas K.;Guo, Bin;Friesner, Daniel L.;Mallik, Sanku
- 通讯作者:Mallik, Sanku
Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery.
- DOI:10.1007/s00466-013-0962-4
- 发表时间:2014-03
- 期刊:
- 影响因子:4.1
- 作者:Paul, Shirshendu;Nahire, Rahul;Mallik, Sanku;Sarkar, Kausik
- 通讯作者:Sarkar, Kausik
Fluorescent polymer-based post-translational differentiation and subtyping of breast cancer cells.
基于荧光聚合物的乳腺癌细胞翻译后分化和亚型分析。
- DOI:10.1039/c2an35877h
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Scott,MichaelD;Dutta,Rinku;Haldar,ManasK;Wagh,Anil;Gustad,ThomasR;Law,Benedict;Friesner,DanielL;Mallik,Sanku
- 通讯作者:Mallik,Sanku
共 9 条
- 1
- 2
Sanku Mallik的其他基金
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
胰腺癌诊断和治疗策略中心
- 批准号:99046789904678
- 财政年份:2016
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
行政核心:胰腺癌诊断和治疗策略中心
- 批准号:1066669210666692
- 财政年份:2016
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
胰腺癌诊断和治疗策略中心
- 批准号:1066669110666691
- 财政年份:2016
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
胰腺癌诊断和治疗策略中心
- 批准号:88130588813058
- 财政年份:2016
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
行政核心:胰腺癌诊断和治疗策略中心
- 批准号:88130598813059
- 财政年份:2016
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Echogenic polymersomes for triggered contents release
用于触发内容物释放的回声聚合物囊泡
- 批准号:1022802910228029
- 财政年份:2015
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Echogenic polymersomes for triggered contents release
用于触发内容物释放的回声聚合物囊泡
- 批准号:1068414710684147
- 财政年份:2015
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Echogenic polymersomes for triggered contents release
用于触发内容物释放的回声聚合物囊泡
- 批准号:1058218610582186
- 财政年份:2015
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Echogenic polymersomes for triggered contents release
用于触发内容物释放的回声聚合物囊泡
- 批准号:99740639974063
- 财政年份:2015
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Echogenic polymersomes for triggered contents release
用于触发内容物释放的回声聚合物囊泡
- 批准号:1046507210465072
- 财政年份:2015
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
相似国自然基金
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:32202823
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
- 批准号:22105008
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
- 批准号:91953103
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:重大研究计划
相似海外基金
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:1049164210491642
- 财政年份:2023
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Biotin Orthogonal Streptavidin System (BOSS) for Drug Pre-Targeting
用于药物预靶向的生物素正交链霉亲和素系统 (BOSS)
- 批准号:1060618010606180
- 财政年份:2023
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:1059784010597840
- 财政年份:2023
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:1075730910757309
- 财政年份:2023
- 资助金额:$ 27.92万$ 27.92万
- 项目类别:
Scalable platforms for understudied histone modifications and modifiers
用于未充分研究的组蛋白修饰和修饰剂的可扩展平台
- 批准号:1056784910567849
- 财政年份:2023
- 资助金额:$ 27.92万$ 27.92万
- 项目类别: